NCT04925180View on ClinicalTrials.gov

A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and SeborrheaHypersexuality in MenSexual Deviations in MenProstate Cancer
Interventions
DRUG

Cyproterone Acetate (Androcur, BAY94-8367)

As prescribed by the treating physician

Trial Locations (5)

Unknown

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY